NYBC Ventures
Signal active
Investment Firm
Overview
New York Blood Center created NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies and technology. The fund was established by New York Blood Center with a $50 million investment and a mission to improve patients' lives by advancing therapeutics, enabling platforms and technologies, and driving collaborations to expand NYBC's impact.
Highlights
Founded
2021
Industry
Employees
11-50
Investment
12
Lead Investment
6
Exits
undefined
Stages
Early Stage Venture, Seed, Late Stage Venture
Investor Type
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
NYBC Ventures, established in 2021 and headquartered in United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Health Care, Medical Device, Health Diagnostics, Social Entrepreneurship, Government, Office Administration, Financial Services, Biotechnology, Life Science, Test and Measurement. Their recent investments include Vitestro, Sonder Capital, European Innovation Council, Invest-NL, Vega Therapeutics. The highest investment round they participated in was $17.5B. Among their most notable exits are Vitestro and Sonder Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
NYBC Ventures has made 12 investments. Their most recent investment was on Apr 30, 2024, when Vitestro raised $21.3M.
investments
12
Diversity investments
1
Lead investments
6
Number of exits
undefined
Investments
12
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Oct 12, 2023 | Aronora | Biotechnology | null |
| Nov 14, 2023 | Vittoria Biotherapeutics | Biotechnology | 15.0M |
| Dec 07, 2023 | Functional Fluidics | Health Care | null |
| Apr 30, 2024 | Vitestro | Health Care | 21.3M |
Exits
0
Funding Timeline
Funding rounds
12
Investors
0
Funds
1
Funding Rounds
12
NYBC Ventures has raised 12 rounds. Their latest funding was raised on Apr 30, 2024 from a Series A - Vitestro round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Oct 12, 2023 | Seed Round - Aronora | - | 0 | - |
| Nov 14, 2023 | Venture Round - Vittoria Biotherapeutics | - | 15.0M | - |
| Dec 07, 2023 | Venture Round - Functional Fluidics | - | 0 | - |
| Apr 30, 2024 | Series A - Vitestro | - | 21.3M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.